1. Home
  2. Analysis
  3. Arnuity-ellipta
  4. Ubrelvy

Arnuity ellipta and Ubrelvy drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Arnuity ellipta (fluticasone furoate) and Ubrelvy (ubrogepant). Common drug interactions include hepatitis a antibody positive among females.

The phase IV clinical study analyzes what interactions people have when they take Arnuity ellipta and Ubrelvy. It is created by eHealthMe based on reports of 6 people who take the same drugs from the FDA, and is updated regularly.

What is Arnuity ellipta?

Arnuity ellipta has active ingredients of fluticasone furoate. eHealthMe is studying from 3,482 Arnuity ellipta users. Check the latest studies of Arnuity ellipta.

What is Ubrelvy?

Ubrelvy has active ingredients of ubrogepant. eHealthMe is studying from 3,583 Ubrelvy users. Check the latest studies of Ubrelvy.

On Dec, 30, 2025

6 people who take Arnuity ellipta and Ubrelvy together, and have interactions are studied.

Arnuity ellipta and Ubrelvy drug interactions.

What are the common drug interactions of Arnuity Ellipta and Ubrelvy, by gender? *:

female:

  1. Hepatitis a antibody positive
  2. Hepatitis b
  3. Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
  4. Pruritus (severe itching of the skin)
  5. Respiratory tract congestion (blockage on respiratory system)
  6. Therapeutic response decreased (less preventive response)
  7. Urticaria (rash of round, red welts on the skin that itch intensely)
  8. Hepatitis b core antibody positive
  9. Injection site reaction
  10. Asthma

male:

n/a

What are the common drug interactions of Arnuity Ellipta and Ubrelvy, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
  2. Pruritus (severe itching of the skin)
  3. Respiratory tract congestion (blockage on respiratory system)
  4. Therapeutic response decreased (less preventive response)
  5. Urticaria (rash of round, red welts on the skin that itch intensely)
  6. Asthma
  7. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  8. Kidney infection

40-49:

  1. Clavicle fracture
  2. Fall
  3. Intervertebral disc protrusion (spinal disc protrusion)

50-59:

n/a

60+:

  1. Hepatitis a antibody positive
  2. Hepatitis b
  3. Hepatitis b core antibody positive
  4. Injection site reaction

* Approximation only. Some reports may have incomplete information.

Do you take Arnuity ellipta and Ubrelvy?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Arnuity ellipta and Ubrelvy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Arnuity ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ubrelvy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Arnuity ellipta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ubrelvy and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone furoate and ubrogepant (the active ingredients of Arnuity ellipta and Ubrelvy, respectively), and Arnuity ellipta and Ubrelvy (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.